Sapropterin

(asked on 7th May 2019) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 November 2018 to Question 190518 on Sapropterin, whether the NICE appraisal of Kuvan will take into account the costs from NHS funded treatments that can be avoided such as food supplements.


Answered by
Seema Kennedy Portrait
Seema Kennedy
This question was answered on 15th May 2019

In developing its recommendations on Kuvan, the National Institute for Health and Care Excellence (NICE) will consider all the health-related costs and benefits associated with the treatment in accordance with its published methods and processes and the scope for the appraisal that has been developed in consultation with stakeholders; potentially including any costs from National Health Service funded treatments that can be avoided such as food supplements. The NICE appraisal of Kuvan is now underway and NICE expects to publish final guidance next year.

Reticulating Splines